PURDUE PHARMA, LP for PURDUE PHARMA LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Copyright/Patent/Trademark CPT
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.